BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 26283540)

  • 1. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.
    Londhe P; Davie JK
    Sci Signal; 2013 Dec; 6(305):ra107. PubMed ID: 24327761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
    Truax AD; Thakkar M; Greer SF
    PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.
    Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
    J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early epigenetic events regulate the adaptive immune response gene CIITA.
    Mehta NT; Truax AD; Boyd NH; Greer SF
    Epigenetics; 2011 Apr; 6(4):516-25. PubMed ID: 21266852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer.
    Chandnani N; Gupta I; Thakkar V; Sarkar K
    Pathol Res Pract; 2023 Nov; 251():154885. PubMed ID: 37862922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.
    Truax AD; Koues OI; Mentel MK; Greer SF
    J Mol Biol; 2010 Jan; 395(2):254-69. PubMed ID: 19853614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.
    Son J; Shen SS; Margueron R; Reinberg D
    Genes Dev; 2013 Dec; 27(24):2663-77. PubMed ID: 24352422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jarid2 and PRC2, partners in regulating gene expression.
    Li G; Margueron R; Ku M; Chambon P; Bernstein BE; Reinberg D
    Genes Dev; 2010 Feb; 24(4):368-80. PubMed ID: 20123894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus.
    Abou El Hassan M; Yu T; Song L; Bremner R
    J Immunol; 2015 May; 194(10):5007-13. PubMed ID: 25862816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
    Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
    J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
    Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
    Tooze RM; Stephenson S; Doody GM
    J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.